Skip to content

US · SCL · CHEMICALS - SPECIALTY

Stepan Co (SCL) intrinsic value and stock valuation

$63.48as of 2026-11-21 · Mkt cap 1.46B

Data updated · price as of 2026-11-21

OvervaluedIC value is 20–50% below the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Stepan Co DCF and intrinsic value

InvestorsCraft values SCL with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from SCL’s statements →

Stepan Co Graham Number

Graham Number: $50.09d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Basic Materials · Chemicals - Specialty Northbrook, IL 60062 stepan.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$2.33B+4.5% 5y CAGRd
20112025
Net income
$46.9M-18% 5y CAGRd
20112025
Free cash flow
$25.4M-25.3% 5y CAGRd
20112025
Total equity
$1.24B+4.7% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$2.33B$2.18B$2.33B$2.77B$2.35B
Operating income$69.4M$70.5M$58.6M$207.3M$170.8M
Net income$46.9M$50.4M$40.2M$147.2M$137.8M
EPSd$2.05M$2.2M$1.75M$6.38M$5.92M
Operating cash flow$147.9M$162.1M$174.9M$160.8M$72.1M
Capital expenditure-$-122.51M-$-122.78M-$-260.33M-$-301.55M-$-194.48M
Free cash flow$25.4M$39.3M-$-85.46M-$-140.79M-$-122.35M
Total assets$2.36B$2.3B$2.36B$2.43B$2.07B
Total debt$691M$682.8M$712.2M$637.7M$420.3M
Net debt$558.4M$583.2M$582.4M$464M$261.1M
Total equity$1.24B$1.17B$1.22B$1.17B$1.07B
Cash and short-term investments$132.7M$99.7M$129.8M$173.8M$159.2M
Income statement
20252024202320222021
Revenue$2.33B$2.18B$2.33B$2.77B$2.35B
Cost of revenue$2.06B$1.91B$2.05B$2.35B$1.95B
Gross profit$269.9M$272.2M$277.6M$427.1M$395.8M
Research and development expenses$59.3M$55.7M$59M$66.6M$62.7M
Selling, general and administrative expenses$139.6M$143.9M$141.6M$161.2M$152.1M
Other expenses$1.67M$2.15M$18.4M-$-8.11M$10.3M
Operating expenses$200.5M$201.7M$219M$219.7M$225M
Cost and expenses$2.26B$2.11B$2.27B$2.57B$2.18B
Interest income$4.11M$5.28M$3.84M$1.08M$1.25M
Interest expense$26.2M$19.5M$16M$10.9M$7.01M
Depreciation and amortization$126M$112.2M$105.3M$94.7M$90.9M
Ebitda$212.2M$192.1M$169.7M$294.2M$270.4M
Operating income$69.4M$70.5M$58.6M$207.3M$170.8M
Total other income/expenses, net-$-9.48M-$-10.04M-$-10.22M-$-18.63M$1.76M
Income before tax$59.9M$60.4M$48.4M$188.7M$172.5M
Income tax expense$13M$10.1M$8.19M$41.6M$34.6M
Net income$46.9M$50.4M$40.2M$147.2M$137.8M
Weighted average shares outstanding$22.9M$22.9M$22.8M$22.8M$22.9M
Weighted average diluted shares outstanding$22.9M$22.9M$23M$23.1M$23.3M
Balance sheet
20252024202320222021
Cash and short-term investments$132.7M$99.7M$129.8M$173.8M$159.2M
Net receivables$388M$388M$422.1M$436.9M$419.5M
Inventory$298.8M$288.7M$265.6M$402.5M$305.5M
Total current assets$859M$810.4M$851.9M$1.04B$913.4M
Property, plant and equipment, net$1.28B$1.27B$1.28B$1.07B$850.6M
Goodwill and intangible assets$132.1M$134M$150M$154M$158M
Long-term investments$21.3M$25.6M$26.8M$23.3M$34.5M
Total non-current assets$1.5B$1.49B$1.51B$1.39B$1.15B
Total assets$2.36B$2.3B$2.36B$2.43B$2.07B
Accounts payable$261.7M$258.8M$233M$375.7M$323.4M
Short-term debt$300.7M$292.8M$252.9M$132.1M$40.7M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$666.5M$669M$607.9M$670.7M$500.5M
Long-term debt$390.3M$390M$459.3M$505.6M$379.5M
Deferred revenue, non-current$2.22M$4.43M$6.65M$8.76M$9.98M
Total non-current liabilities$447.2M$465.7M$539M$596.5M$490.9M
Capital lease obligations$49.3M$57.4M$58M$50.6M$56.7M
Total liabilities$1.11B$1.13B$1.15B$1.27B$991.4M
Common stock$27.3M$27.2M$27M$26.8M$26.8M
Retained earnings$1.29B$1.27B$1.26B$1.25B$1.13B
Accumulated other comprehensive income (loss)-$-138.97M-$-196.84M-$-130.6M-$-167.51M-$-153.24M
Total equity$1.24B$1.17B$1.22B$1.17B$1.07B
Total investments$21.3M$25.6M$26.8M$23.3M$34.5M
Total debt$691M$682.8M$712.2M$637.7M$420.3M
Net debt$558.4M$583.2M$582.4M$464M$261.1M
Cash flow statement
20252024202320222021
Net income$46.9M$50.4M$40.2M$147.2M$137.9M
Depreciation and amortization$126M$112.2M$105.3M$94.7M$90.9M
Stock-based compensation$2.15M$5.35M$5.74M$13.9M$11.7M
Change in working capital-$-22.04M$2.79M-$-1.93M-$-68.96M-$-141.51M
Accounts receivable$23.7M$9.04M$32M-$-54.17M-$-104.23M
Inventory$500K-$-37.18M$144.9M-$-99.39M-$-79.26M
Accounts payable-$-32.71M$34M-$-158.92M$54.2M$44.4M
Net cash provided by operating activities$147.9M$162.1M$174.9M$160.8M$72.1M
Investments in property, plant and equipment-$-122.51M-$-122.78M-$-260.33M-$-301.55M-$-194.48M
Acquisitions, net$26.6M$0.00$0.00-$-9.69M-$-184.47M
Net cash used for investing activities-$-89.05M-$-116.94M-$-258.67M-$-308.09M-$-376.83M
Common stock issued$100K$1.11M$2.79M$780K$1.37M
Common stock repurchased$0.00$0.00$0.00-$-24.95M-$-16.97M
Dividends paid-$-35.03M-$-33.95M-$-32.87M-$-30.57M-$-28.08M
Net cash used for financing activities-$-35.44M-$-64.52M$33.3M$166.2M$117.3M
Net change in cash$33M-$-30.16M-$-43.93M$14.6M-$-190.75M
Cash at end of period$132.7M$99.7M$129.8M$173.8M$159.2M
Operating cash flow$147.9M$162.1M$174.9M$160.8M$72.1M
Capital expenditure-$-122.51M-$-122.78M-$-260.33M-$-301.55M-$-194.48M
Free cash flow$25.4M$39.3M-$-85.46M-$-140.79M-$-122.35M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Stepan Co

        Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used in consumer and industrial cleaning and disinfection products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, lubricating ingredients; emulsifiers for spreading agricultural products; and industrial applications comprising latex systems, plastics, and composites. The Polymers segment provides polyurethane polyols that are used in the manufacture of rigid foam for thermal insulation in the construction industry, as well as a base raw material for coatings, adhesives, sealants, and elastomers (CASE); polyester resins used in coating applications; specialty polyols, such as CASE and powdered polyester resins; and phthalic anhydride that is used in unsaturated polyester resins, alkyd resins, and plasticizers for applications in construction materials, as well as components of automotive, boating, and other consumer products. The Specialty Products segment offers flavors, emulsifiers, and solubilizers for use in food, flavoring, nutritional supplement, and pharmaceutical applications. Stepan Company was founded in 1932 and is headquartered in Northbrook, Illinois.

        CEO
        Luis E. Rojo
        Employees
        2.33K
        Beta
        0.95

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of Stepan Co (SCL)?

        Stepan Co (SCL) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is SCL undervalued?

        SCL trades at a price of $63.48 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.